Alto Neuroscience, Inc.
ANRO
$13.85
$0.342.52%
NYSE
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -20.37% | -2.53% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -19.97% | 19.18% | |||
| Operating Income | 19.97% | -19.18% | |||
| Income Before Tax | 19.91% | -16.72% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 19.91% | -16.72% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 19.91% | -16.72% | |||
| EBIT | 19.97% | -19.18% | |||
| EBITDA | 20.13% | -19.40% | |||
| EPS Basic | 20.00% | -16.62% | |||
| Normalized Basic EPS | 20.01% | -22.10% | |||
| EPS Diluted | 20.00% | -16.62% | |||
| Normalized Diluted EPS | 20.01% | -22.10% | |||
| Average Basic Shares Outstanding | 0.12% | 0.09% | |||
| Average Diluted Shares Outstanding | 0.12% | 0.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||